Downregulation of PTEN was significant in high-grade carcinoma compared with those in normal mammary gland, adenoma, and low-grade carcinoma (Figure 4, p = 0.03; p < 0.001; p = 0.009). This evidence concerns the gene PTEN and carcinoma.